Skip to main content
OpenTrials

Clinical trial condition

Myelofibrosis

Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.

173 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Myelofibrosis trial results

Recruiting

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

NCT04771572

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +48 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

Methods of T Cell Depletion Trial (MoTD)

NCT04888741

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +39 more
Locations
  • University Hospital of Wales Cardiff, Wales, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrookes Hospital Cambridge, United Kingdom
View all 17 locations
View Trial Details
Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

NCT04176198

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
View all 84 locations
View Trial Details
Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details

Related conditions